We plan to begin the subject audit in May 2022. The objective of this audit is to determine whether the Defense Health Agency has effective controls to monitor opioid prescriptions from providers to ensure compliance with Federal and DoD opioid safety standards. We may revise the objective as the audit proceeds, and we will also consider suggestions from management for additional or revised objectives.